Cobamamide
BLOOD AND BLOOD FORMING ORGANS
Also known as: adenosylcobalamin, cobalamin coenzyme, Vitamin B12 coenzyme
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Cobamamide is a drug catalogued in DrugCentral. Recorded indications include Prevention of Vitamin B12 Deficiency.
- Indications: Prevention of Vitamin B12 Deficiency.
- ATC code: B03BA04 (Vitamin B12 (cyanocobalamin and analogues)).
- Molecular formula: C72H100CoN18O17P; molecular weight 1579.61 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Prevention of Vitamin B12 Deficiency
Contraindications (4)
- Atrophic gastritis
- Gastrectomy
- Hypokalemia
- Leber's optic atrophy
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
B03BA04 | BLOOD AND BLOOD FORMING ORGANS › ANTIANEMIC PREPARATIONS › VITAMIN B12 AND FOLIC ACID › Vitamin B12 (cyanocobalamin and analogues) |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Ejection fraction abnormal | 113.7 |
| Sensitisation | 110.2 |
| Ultrasound antenatal screen | 105.7 |
| Polycystic ovaries | 103.6 |
| Trisomy 18 | 99.4 |
| Hydrops foetalis | 95.3 |
| Needle fatigue | 85.5 |
| Cleft lip and palate | 82.9 |
| Gait spastic | 81.5 |
| Relapsing-remitting multiple sclerosis | 76.1 |
| Carpal tunnel syndrome | 72.4 |
| Ejection fraction | 71.5 |
Chemical structure
| Molecular formula | C72H100CoN18O17P |
|---|---|
| Molecular weight | 1579.61 g/mol |
| CAS number | 13870-90-1 |
| InChIKey | — |
| PubChem CID | 131635025 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Cobamamide used for?
DrugCentral lists the following indications for Cobamamide: Prevention of Vitamin B12 Deficiency.
What is the chemical formula of Cobamamide?
Cobamamide has the molecular formula C72H100CoN18O17P and a molecular weight of 1579.61 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4404 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3833359 — compound record and bioactivity
- PubChem CID 131635025 — chemical identifiers
- DrugBank DB11191 — drug record
- FDA UNII F0R1QK73KB — substance identity
- DailyMed: FDA labels for Cobamamide — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.